Our laboratory has demonstrated that activation of PKCɛ, in the absence of IPC, is sufficient to activate neuroprotection, whereas, inhibition of PKCε blunts IPC mediated neuroprotection against cerebral ischemia [8-10]. The gene discussed is PRKCE; the disease is brain ischemia.